Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,261 | 121,406 | 33,638 | 12,528 | 16,530 |
| Marketable Securities | 35,734 | 84,951 | 40,340 | 118,569 | 23,671 |
| Receivables | 4,047 | N/A | N/A | N/A | N/A |
| Inventories | 2,316 | N/A | N/A | N/A | N/A |
| Other current assets | 4,801 | 6,905 | 7,094 | 6,831 | 4,340 |
| TOTAL | $85,159 | $213,262 | $81,072 | $137,928 | $44,541 |
| Non-Current Assets | |||||
| PPE Net | 42,501 | 25,154 | 28,206 | 32,560 | 20,715 |
| Investments And Advances | 23,129 | 12,007 | 0 | 0 | 1,482 |
| Intangibles | 61,504 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 20,673 | 5,917 | 1,338 | 1,323 | 10,195 |
| TOTAL | $147,807 | $43,078 | $29,544 | $33,883 | $32,392 |
| Total Assets | $232,966 | $256,340 | $110,616 | $171,811 | $76,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 42,805 | 2,717 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 27,249 | 10,098 | 3,930 | 6,482 | 4,647 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1,951 |
| Other current liabilities | N/A | N/A | 2,917 | 1,591 | 0 |
| TOTAL | $70,054 | $12,815 | $6,847 | $8,302 | $6,883 |
| Non-Current Liabilities | |||||
| Long Term Debt | 103,038 | 672 | N/A | N/A | 56 |
| Other Non-Current Liabilities | 127,852 | 125,000 | 5,226 | 3,961 | 0 |
| TOTAL | $230,890 | $125,672 | $5,226 | $3,961 | $56 |
| Total Liabilities | $300,944 | $138,487 | $12,073 | $12,263 | $6,939 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,511 | 64,228 | 53,864 | 52,447 | N/A |
| Common Shares | 65 | 64 | 54 | 52 | 37 |
| Retained earnings | -488,821 | -301,378 | -225,580 | -148,119 | -80,513 |
| Other shareholders' equity | -363 | 5,057 | 5,031 | 2,385 | -3,470 |
| TOTAL | $-67,978 | $117,853 | $98,543 | $159,548 | $69,994 |
| Total Liabilities And Equity | $232,966 | $256,340 | $110,616 | $171,811 | $76,933 |